Literature DB >> 8627786

Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.

L Yuan1, L A Ward, B I Rosen, T L To, L J Saif.   

Abstract

Neonatal gnotobiotic pigs orally inoculated with virulent (intestinal-suspension) Wa strain human rotavirus (which mimics human natural infection) developed diarrhea, and most pigs which recovered (87% protection rate) were immune to disease upon homologous virulent virus challenge at postinoculation day (PID) 21. Pigs inoculated with cell culture-attenuated Wa rotavirus (which mimics live oral vaccines) developed subclinical infections and seroconverted but were only partially protected against challenge (33% protection rate). Isotype-specific antibody-secreting cells (ASC were enumerated at selected PID in intestinal (duodenal and ileal lamina propria and mesenteric lymph node [MLN]) and systemic (spleen and blood) lymphoid tissues by using enzyme-linked immunospot assays. At challenge (PID 21), the numbers of virus-specific immunoglobulin A (IgA) ASC, but not IgG ASC, in intestines and blood were significantly greater in virulent-Wa rotavirus-inoculated pigs than in attenuated-Wa rotavirus-inoculated pigs and were correlated (correlation coefficients: for duodenum and ileum, 0.9; for MLN, 0.8; for blood, 0.6) with the degree of protection induced. After challenge, the numbers of IgA and IgG virus-specific ASC and serum-neutralizing antibodies increased significantly in the attenuated-Wa rotavirus-inoculated pigs but not in the virulent-Wa rotavirus-inoculated pigs (except in the spleen and except for IgA ASC in the duodenum). The transient appearance of IgA ASC in the blood mirrored the IgA ASC responses in the gut, albeit at a lower level, suggesting that IgA ASC in the blood of humans could serve as an indicator for IgA ASC responses in the intestine after rotavirus infection. To our knowledge, this is the first report to study and identify intestinal IgA ASC as a correlate of protective active immunity in an animal model of human-rotavirus-induced disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627786      PMCID: PMC190169     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Rotavirus serotypes causing severe acute diarrhea in young children in six Australian cities, 1989 to 1992.

Authors:  P J Masendycz; L E Unicomb; C D Kirkwood; R F Bishop
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

2.  Analyses of homologous rotavirus infection in the mouse model.

Authors:  J W Burns; A A Krishnaney; P T Vo; R V Rouse; L J Anderson; H B Greenberg
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

3.  Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus.

Authors:  N Feng; J W Burns; L Bracy; H B Greenberg
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 4.  Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children.

Authors:  Y Hoshino; A Z Kapikian
Journal:  Trends Microbiol       Date:  1994-07       Impact factor: 17.079

5.  Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections.

Authors:  M L O'Ryan; D O Matson; M K Estes; L K Pickering
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

6.  Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.

Authors:  M M McNeal; R L Broome; R L Ward
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

7.  Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture.

Authors:  C A Khoury; K A Brown; J E Kim; P A Offit
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

8.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model.

Authors:  Y Hoshino; L J Saif; S Y Kang; M M Sereno; W K Chen; A Z Kapikian
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

10.  Enumeration of isotype-specific antibody-secreting cells derived from gnotobiotic piglets inoculated with porcine rotaviruses.

Authors:  W K Chen; T Campbell; J VanCott; L J Saif
Journal:  Vet Immunol Immunopathol       Date:  1995-04       Impact factor: 2.046

View more
  113 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Protein Malnutrition Alters Tryptophan and Angiotensin-Converting Enzyme 2 Homeostasis and Adaptive Immune Responses in Human Rotavirus-Infected Gnotobiotic Pigs with Human Infant Fecal Microbiota Transplant.

Authors:  David D Fischer; Sukumar Kandasamy; Francine C Paim; Stephanie N Langel; Moyasar A Alhamo; Lulu Shao; Juliet Chepngeno; Ayako Miyazaki; Huang-Chi Huang; Anand Kumar; Gireesh Rajashekara; Linda J Saif; Anastasia N Vlasova
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

3.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype.

Authors:  Monica M McNeal; Karol Sestak; Anthony H-C Choi; Mitali Basu; Michael J Cole; Pyone P Aye; Rudolf P Bohm; Richard L Ward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.

Authors:  Fangning Liu; Guohua Li; Ke Wen; Shaoping Wu; Yongguo Zhang; Tammy Bui; Xingdong Yang; Jacob Kocher; Jun Sun; Bernard Jortner; Lijuan Yuan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-12       Impact factor: 2.839

6.  Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.

Authors:  Sukumar Kandasamy; Kuldeep S Chattha; Anastasia N Vlasova; Gireesh Rajashekara; Linda J Saif
Journal:  Gut Microbes       Date:  2014

7.  Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.

Authors:  Lijuan Yuan; Ke Wen; Marli S P Azevedo; Ana M Gonzalez; Wei Zhang; Linda J Saif
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

8.  Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine.

Authors:  Kuldeep S Chattha; Anastasia N Vlasova; Sukumar Kandasamy; Malak A Esseili; Christine Siegismund; Gireesh Rajashekara; Linda J Saif
Journal:  Vaccine       Date:  2013-02-21       Impact factor: 3.641

9.  Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.

Authors:  S C Chen; D H Jones; E F Fynan; G H Farrar; J C Clegg; H B Greenberg; J E Herrmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Prenatally acquired vitamin A deficiency alters innate immune responses to human rotavirus in a gnotobiotic pig model.

Authors:  Anastasia N Vlasova; Kuldeep S Chattha; Sukumar Kandasamy; Christine S Siegismund; Linda J Saif
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.